Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Anchusa azurea
Perennial Mediterranean herb with brilliant blue flowers; used in traditional Mediterranean and Middle Eastern medicine for respiratory and skin conditions.
Oxtongue Bugloss (Anchusa azurea) is a perennial Mediterranean herb from the Boraginaceae family, traditionally used for respiratory catarrh and skin conditions due to its demulcent and astringent properties. Its primary active compounds include mucilage, tannins, flavonoids, and pyrrolizidine alkaloids (PAs), which confer both therapeutic effects and significant hepatotoxic risk. Evidence is limited to traditional use and preliminary studies, with no robust clinical trials supporting efficacy.
The mucilage content forms a protective film over mucous membranes, providing demulcent and soothing effects in respiratory and gastrointestinal tissues. Tannins exert astringent and anti-inflammatory actions by precipitating proteins and reducing capillary permeability. Pyrrolizidine alkaloids, such as lycopsamine, are metabolized in the liver by cytochrome P450 enzymes to toxic pyrrole derivatives that can cause veno-occlusive disease and hepatotoxicity. Flavonoids contribute antioxidant and anti-inflammatory activity via inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) pathways.
Perennial Mediterranean herb with brilliant blue flowers; used in traditional Mediterranean and Middle Eastern medicine for respiratory and skin conditions.
Oxtongue Bugloss (Anchusa azurea) is a perennial Mediterranean herb from the Boraginaceae family, traditionally used for respiratory catarrh and skin conditions due to its demulcent and astringent properties. Its primary active compounds include mucilage, tannins, flavonoids, and pyrrolizidine alkaloids (PAs), which confer both therapeutic effects and significant hepatotoxic risk. Evidence is limited to traditional use and preliminary studies, with no robust clinical trials supporting efficacy.
The mucilage content forms a protective film over mucous membranes, providing demulcent and soothing effects in respiratory and gastrointestinal tissues. Tannins exert astringent and anti-inflammatory actions by precipitating proteins and reducing capillary permeability. Pyrrolizidine alkaloids, such as lycopsamine, are metabolized in the liver by cytochrome P450 enzymes to toxic pyrrole derivatives that can cause veno-occlusive disease and hepatotoxicity. Flavonoids contribute antioxidant and anti-inflammatory activity via inhibition of cyclooxygenase (COX) and lipoxygenase (LOX) pathways.